News
Is CRISPR Therapeutics the NVIDIA of gene editing?
CRISPR Therapeutics AG (NASDAQ: CRSP) made worldwide headlines when it and partner Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) received the first-ever FDA approval for a gene-editing therapy for
Is CRISPR Therapeutics the NVIDIA of gene editing?
CRISPR Therapeutics AG (NASDAQ: CRSP) made worldwide headlines when it and partner Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) received the first-ever FDA approval for a gene-editing therapy for
Is CRISPR Therapeutics the NVIDIA of gene editing?
CRISPR Therapeutics AG (NASDAQ: CRSP) made worldwide headlines when it and partner Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) received the first-ever FDA approval for a gene-editing therapy for
Analysts boosted Snowflake stock, big firms are buying now
All the market hype is now focusing on the world of technology stocks, especially after the massive run-up in names like Nvidia Corporation (NASDAQ: NVDA) and other companies involved with the
Analysts boosted Snowflake stock, big firms are buying now
All the market hype is now focusing on the world of technology stocks, especially after the massive run-up in names like Nvidia Corporation (NASDAQ: NVDA) and other companies involved with the
Analysts boosted Snowflake stock, big firms are buying now
All the market hype is now focusing on the world of technology stocks, especially after the massive run-up in names like Nvidia Corporation (NASDAQ: NVDA) and other companies involved with the
Aus 10.000 EUR wurden mit Bitcoin ($BTC) 1,34 Mrd. EUR. Sensationelle Übernahme - Diese Krypto-Aktie jetzt kaufen. Neuer 297% Crypto Hot Stock nach 5.544% mit Ethereum ($ETH) und 1.337.328% mit Bitcoin ($BTC)
Aus 10.000 EUR wurden mit Bitcoin ($BTC) 1,34 Mrd. EUR. Sensationelle Übernahme - Diese Krypto-Aktie jetzt kaufen
26.02.24 - AC Research
Vancouver (www.aktiencheck.de, Anzeige)
Link
Blockbuster gegen Krebs - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Blockbuster gegen Krebs - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 134.452% mit Biogen ($BIIB)
26.02.24
London (www.aktiencheck.de, Anzeige)
Link
Blockbuster gegen Krebs - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Blockbuster gegen Krebs - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 134.452% mit Biogen ($BIIB)
26.02.24
London (www.aktiencheck.de, Anzeige)
Link
Blockbuster gegen Krebs - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Blockbuster gegen Krebs - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 134.452% mit Biogen ($BIIB)
26.02.24
London (www.aktiencheck.de, Anzeige)
Link
Dropbox’s stock is a falling knife worth catching
When does a falling knife become just too tempting not to try and catch? With the broader equity market surging to record highs on the back of a risk-on sentiment that keeps getting stronger
Warner Bros. Discover: Debt down, profits up, yet questions remain
Warner Bros. Discovery (NASDAQ: WBD) is the media and entertainment sector powerhouse born from the 2022 merger of WarnerMedia and Discovery. Warner Bros. Discovery’s earnings report for Q4 2023
Bloomin’ Brands could blossom in 2024
Bloomin’ Brands (NASDAQ: BLMN) served mixed results for Q4 and provided tepid guidance, but repositioning efforts have the restaurant stock set up to blossom in 2024. A massive closure effort
Novavax’s dispute resolution and upcoming earnings call
Novavax (NASDAQ: NVAX) is a biotechnology pioneer dedicated to developing innovative vaccines against serious infectious diseases. Their unique approach utilizes protein-based technology, an
Dell Technologies breaks out ahead of earnings release
Ahead of its upcoming earnings report on February 29, Dell Technologies (NYSE: DELL) just broke out of a lengthy consolidation. Year-to-date, the technology and computer giant is now up almost 15%
Bitcoin ($BTC) über 51.500$ - Sensationelle Krypto-Übernahme. 77 Milliarden $ Deals - Diese Krypto-Aktie jetzt kaufen. Neuer 297% Crypto Hot Stock nach 5.544% mit Ethereum ($ETH) und 1.337.328% mit Bitcoin ($BTC)
Bitcoin ($BTC) über 51.500$ - Sensationelle Krypto-Übernahme. 77 Milliarden $ Deals - Diese Krypto-Aktie jetzt kaufen
23.02.24 08:18
Vancouver (www.aktiencheck.de , Anzeige)
Eilt: Hautkrebs vollständig geheilt - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Hautkrebs vollständig geheilt - 100 mal wirksamer gegen Krebs. 415% Biotech Hot Stock nach 15.973% mit BioNTech
23.02.24 08:03
London (www.aktiencheck.de , Anzeige)
Eilt: Hautkrebs vollständig geheilt - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Hautkrebs vollständig geheilt - 100 mal wirksamer gegen Krebs. 415% Biotech Hot Stock nach 15.973% mit BioNTech
23.02.24 08:03
London (www.aktiencheck.de , Anzeige)
Eilt: Hautkrebs vollständig geheilt - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Hautkrebs vollständig geheilt - 100 mal wirksamer gegen Krebs. 415% Biotech Hot Stock nach 15.973% mit BioNTech
23.02.24 08:03
London (www.aktiencheck.de , Anzeige)
Keurig-Dr Pepper stock: Time to take another sip?
Keurig Dr Pepper's (NASDAQ: KDP) share price fell following the Q4 results and guidance for 2024, setting up the next buying opportunity. The market is down but aligning with a bottoming pattern
Keurig-Dr Pepper stock: Time to take another sip?
Keurig Dr Pepper's (NASDAQ: KDP) share price fell following the Q4 results and guidance for 2024, setting up the next buying opportunity. The market is down but aligning with a bottoming pattern
The Trade Desk: 3 reasons to buy before a new all-time high
After a lackluster second half to 2023, shares of The Trade Desk, Inc. (NASDAQ: TTD) are once again doing what they love best: rallying. Truth be told, it was starting to look like they were
The Trade Desk: 3 reasons to buy before a new all-time high
After a lackluster second half to 2023, shares of The Trade Desk, Inc. (NASDAQ: TTD) are once again doing what they love best: rallying. Truth be told, it was starting to look like they were
Roku stock and the mother of all entry opportunities
The 30% drop from their pre-earnings share price should tell you everything you need to know about Roku, Inc.’s (NASDAQ: ROKU) earnings report. The streaming giant reported their Q4 numbers last
Rivian shares gets discounted; shares can move lower
Rivian’s (NASDAQ: RIVN) Q4 release further proves that the EV market bubble has burst. Internal metrics and guidance suggest demand has peaked and current capacity is too much. The takeaway is